Advantages of the lognormal approach to determining reference change values for N-terminal propeptide B-type natriuretic peptide
Authors:
- Catherine KlersyCKCatherine Klersy
- Gian Vico Melzi D'ERilGDGian Vico Melzi D'ERil
- Alessandra BarassiABAlessandra Barassi
- Giovanni PalladiniGiovanni Palladini
- Mario ComelliMCMario Comelli
- Remigio MorattiRMRemigio Moratti
- Riccardo AlbertiniRARiccardo Albertini
- Giampaolo MerliniGMGiampaolo Merlini
- 1 March 2012
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 413 (5-6) , 544-547
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- B-Type Natriuretic Peptide–Guided Heart Failure TherapyArchives of internal medicine (1960), 2010
- Natriuretic peptides in heart failure: should therapy be guided by BNP levels?Nature Reviews Cardiology, 2009
- Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trialsAmerican Heart Journal, 2009
- Only Large Reductions in Concentrations of Natriuretic Peptides (BNP and NT-proBNP) Are Associated with Improved Outcome in Ambulatory Patients with Chronic Heart FailureClinical Chemistry, 2009
- Chapter 7 Clinical Relevance of BNP Measurement in the Follow‐Up of Patients with Chronic Heart Failure2009
- Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)JACC, 2008
- How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic reviewBMJ, 2005
- N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure PatientsCirculation, 2004
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000
- Generation and Application of Data on Biological Variation in Clinical ChemistryCritical Reviews in Clinical Laboratory Sciences, 1989